AlphAIAlphAI — Financial news for AI agents
yahoo.comAUG 282 min read$SNX

3 Value Stocks with Growth for Your Watch List

Zacks Value Investor Podcast highlights 3 stocks with growth and value: TD SYNNEX (SNX) reported record revenue, raised dividend; Oscar Health (OSCR) raised guidance, estimates; PBF Energy (PBF) reduced debt, saw earnings growth. All are Zacks #1 Rank (Strong Buy).

Original reporting
yahoo.com
Published Aug 28, 2026, 10:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 28, 2026, 11:29 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefFinancial news
Primary signal
$SNX
Bullish
medium confidence
Mentioned
$SNX · $OSCR · $PBF
Relevance
4/10
AlphAI data visualization · based on yahoo.com
Decision brief

The 30-second read

$SNXBullishLow
01

Why it matters

The article recaps recent earnings and guidance lifts, offering limited new actionable insight.

02

Market read

The piece serves as a watch‑list recommendation rather than a primary news disclosure.

03

What to watch

Potential supply‑chain risks for SNX and regulatory changes for OSCR could affect future performance.

Relevance 4/10Novelty 2/10Timing: none

Background

A podcast episode presents three Zacks #1‑ranked stocks with strong growth metrics and recent earnings highlights.

Company-level read

Ticker impact

$SNXBullishMedium confidence
Context

TD SYNNEX reported record Q2 2026 revenue up 31% and earnings growth expectations of 41.7% for fiscal 2026.

Expected impact

Modest upside over the next weeks if guidance holds.

Evidence & confidence

Revenue and earnings growth are strong, but the stock has already fallen from a #1 to #3 rank, indicating mixed market reaction.

$OSCRBullishMedium confidence
Context

Oscar Health posted record H1 2026 results and raised full‑year guidance, with consensus earnings forecast jumping to $1.54.

Expected impact

Likely short‑term rally as investors price in higher earnings.

Evidence & confidence

Guidance increase is sizable (191% growth) but the company remains loss‑making, limiting upside.

$PBFBullishMedium confidence
Context

PBF Energy reported strong Q2 2026 results, cutting debt by $1 bn and raising earnings consensus to $15.74.

Expected impact

Potential moderate upside as the market digests improved profitability.

Evidence & confidence

High earnings growth (481%) and low P/E suggest value, yet the sector’s volatility tempers confidence.

Market effects

Sector

Highlights value opportunities in technology distribution, health‑tech, and refining sectors.

Regional

U.S. focused; no broader regional effect noted.

Global

Limited to investors tracking mid‑cap U.S. equities.

Counterpoint

What could challenge this read

Recent price gains may already price in growth, leaving limited upside.

Key entities

  • company
    TD SYNNEX Corp.

    Technology distributor with record Q2 2026 results.

  • company
    Oscar Health, Inc.

    Health‑tech insurer with raised full‑year guidance.

  • company
    PBF Energy Inc.

    Refiner reporting strong Q2 2026 earnings and debt reduction.

Read at source← All news

Related articles

SEP 16
$OSCRHighAI 8/10

OSCR Looks 33.9% Overvalued on GF Value™ as Oscar Health Revises

Oscar Health (OSCR) revised its 2026 forecasts, raising operating earnings outlook by $100M to $600M-$800M and improving medical loss ratio guidance. Revenue guidance remains $18.7B-$19B. GF Value™ indicates OSCR is 33.9% overvalued at $32.44. The company has a strong GF Score™ of 83/100, with high growth and momentum ratings but middling profitability and valuation. Insiders have sold significantly more shares than they've bought.

gurufocus.com2 min
SEP 16
$OSCRHighAI 8/10

Oscar Health boosts 2026 earnings outlook, affirms revenue

Oscar Health (OSCR) updated its 2026 earnings outlook, lowering its Medical Loss Ratio to 81.0%-82.0% and raising earnings from operations to $600M-$800M. The company reaffirmed revenue guidance of $18.7B-$19.0B and maintained SG&A expense ratio targets. The updates will be discussed at its 2026 Investor Day on September 16, 2026.

tipranks.com2 min
SEP 16
$OSCRHighAI 8/10

Oscar Health raises FY26 earnings guidance by $100 million

Oscar Health (OSCR) raised its 2026 earnings guidance by $100 million, citing improved cost controls. The company expects earnings from operations to range from $600 million to $800 million, with a medical loss ratio of 81.0% to 82.0%. Total revenue guidance remains unchanged at $18.7 billion to $19.0 billion. The stock has gained 85.57% over the past year, reaching a 52-week high of $27.59.

scanx.trade2 min